Cargando…

Risk of carotid blowout after reirradiation with particle therapy

PURPOSE: Carotid blowout (CB) is a serious complication in retreatment of neoplasms in the head and neck (H&N) region. Rates seem to increase in hypofractionated or accelerated hyperfractionated regimens. In this study, we investigate the CB rate and the cumulative doses received by the carotid...

Descripción completa

Detalles Bibliográficos
Autores principales: Dale, Jon Espen, Molinelli, Silvia, Ciurlia, Elisa, Ciocca, Mario, Bonora, Maria, Vitolo, Viviana, Mirandola, Alfredo, Russo, Stefania, Orecchia, Roberto, Dahl, Olav, Fossati, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605322/
https://www.ncbi.nlm.nih.gov/pubmed/29114615
http://dx.doi.org/10.1016/j.adro.2017.05.007
_version_ 1783264967273742336
author Dale, Jon Espen
Molinelli, Silvia
Ciurlia, Elisa
Ciocca, Mario
Bonora, Maria
Vitolo, Viviana
Mirandola, Alfredo
Russo, Stefania
Orecchia, Roberto
Dahl, Olav
Fossati, Piero
author_facet Dale, Jon Espen
Molinelli, Silvia
Ciurlia, Elisa
Ciocca, Mario
Bonora, Maria
Vitolo, Viviana
Mirandola, Alfredo
Russo, Stefania
Orecchia, Roberto
Dahl, Olav
Fossati, Piero
author_sort Dale, Jon Espen
collection PubMed
description PURPOSE: Carotid blowout (CB) is a serious complication in retreatment of neoplasms in the head and neck (H&N) region. Rates seem to increase in hypofractionated or accelerated hyperfractionated regimens. In this study, we investigate the CB rate and the cumulative doses received by the carotid artery (CA) in a cohort of patients who were reirradiated at CNAO with particle therapy in the H&N region. METHODS AND MATERIALS: The dosimetric information, medical records, and tumor characteristics of 96 patients were analyzed. For 49 of these patients, the quality of dosimetric information was sufficient to calculate the cumulative doses to the CA. The corresponding biological equivalent dose in 2 Gy fractions (EQD2) was calculated with an α/β-ratio of 3. RESULTS: In the final reirradiation at CNAO, 17 patients (18%) had been treated with protons and 79 (82%) with carbon ions. Two patients experienced profuse oronasal bleeding, of which one case was confirmed to be caused by CB. If attributing both cases to CB, we found an actuarial CB rate of 2.7%. Interestingly, there were no CB cases in the carbon ion group even though this was the large majority of patients and they generally were treated more aggressively in terms of larger fraction doses and higher cumulative EQD2. CONCLUSIONS: The current practice of particle reirradiation at CNAO for recurrent neoplasms in the H&N region results in acceptable rates of CB.
format Online
Article
Text
id pubmed-5605322
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56053222017-11-07 Risk of carotid blowout after reirradiation with particle therapy Dale, Jon Espen Molinelli, Silvia Ciurlia, Elisa Ciocca, Mario Bonora, Maria Vitolo, Viviana Mirandola, Alfredo Russo, Stefania Orecchia, Roberto Dahl, Olav Fossati, Piero Adv Radiat Oncol Scientific Article PURPOSE: Carotid blowout (CB) is a serious complication in retreatment of neoplasms in the head and neck (H&N) region. Rates seem to increase in hypofractionated or accelerated hyperfractionated regimens. In this study, we investigate the CB rate and the cumulative doses received by the carotid artery (CA) in a cohort of patients who were reirradiated at CNAO with particle therapy in the H&N region. METHODS AND MATERIALS: The dosimetric information, medical records, and tumor characteristics of 96 patients were analyzed. For 49 of these patients, the quality of dosimetric information was sufficient to calculate the cumulative doses to the CA. The corresponding biological equivalent dose in 2 Gy fractions (EQD2) was calculated with an α/β-ratio of 3. RESULTS: In the final reirradiation at CNAO, 17 patients (18%) had been treated with protons and 79 (82%) with carbon ions. Two patients experienced profuse oronasal bleeding, of which one case was confirmed to be caused by CB. If attributing both cases to CB, we found an actuarial CB rate of 2.7%. Interestingly, there were no CB cases in the carbon ion group even though this was the large majority of patients and they generally were treated more aggressively in terms of larger fraction doses and higher cumulative EQD2. CONCLUSIONS: The current practice of particle reirradiation at CNAO for recurrent neoplasms in the H&N region results in acceptable rates of CB. Elsevier 2017-07-06 /pmc/articles/PMC5605322/ /pubmed/29114615 http://dx.doi.org/10.1016/j.adro.2017.05.007 Text en © 2017 The Authors on behalf of the American Society for Radiation Oncology http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Article
Dale, Jon Espen
Molinelli, Silvia
Ciurlia, Elisa
Ciocca, Mario
Bonora, Maria
Vitolo, Viviana
Mirandola, Alfredo
Russo, Stefania
Orecchia, Roberto
Dahl, Olav
Fossati, Piero
Risk of carotid blowout after reirradiation with particle therapy
title Risk of carotid blowout after reirradiation with particle therapy
title_full Risk of carotid blowout after reirradiation with particle therapy
title_fullStr Risk of carotid blowout after reirradiation with particle therapy
title_full_unstemmed Risk of carotid blowout after reirradiation with particle therapy
title_short Risk of carotid blowout after reirradiation with particle therapy
title_sort risk of carotid blowout after reirradiation with particle therapy
topic Scientific Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605322/
https://www.ncbi.nlm.nih.gov/pubmed/29114615
http://dx.doi.org/10.1016/j.adro.2017.05.007
work_keys_str_mv AT dalejonespen riskofcarotidblowoutafterreirradiationwithparticletherapy
AT molinellisilvia riskofcarotidblowoutafterreirradiationwithparticletherapy
AT ciurliaelisa riskofcarotidblowoutafterreirradiationwithparticletherapy
AT cioccamario riskofcarotidblowoutafterreirradiationwithparticletherapy
AT bonoramaria riskofcarotidblowoutafterreirradiationwithparticletherapy
AT vitoloviviana riskofcarotidblowoutafterreirradiationwithparticletherapy
AT mirandolaalfredo riskofcarotidblowoutafterreirradiationwithparticletherapy
AT russostefania riskofcarotidblowoutafterreirradiationwithparticletherapy
AT orecchiaroberto riskofcarotidblowoutafterreirradiationwithparticletherapy
AT dahlolav riskofcarotidblowoutafterreirradiationwithparticletherapy
AT fossatipiero riskofcarotidblowoutafterreirradiationwithparticletherapy